CVM
CVM
AMEX · Biotechnology

Cel-Sci Corp

$5.00
+0.10 (+2.04%)
As of Feb 8, 2:20 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +808.4% upside
Low Target $30.66
Average Target $45.42
High Target $56.99
Current Price $5.00
Current
$5.00
Target
$45.42
$30.66 $45.42 avg $56.99
Scenario Analysis
Bear Case
$30.66
513.2%
Low target
Base Case
$45.42
+808.4%
Avg target
Bull Case
$56.99
+1,039.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$57.14
-91.2% from high
52-Week Low
$24.79
+-79.8% from low
Target vs 52W High
$45.42
-20.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%